Chang Gung Biotechnology Corp.

Jan Martel

Chih-Jung Chang

Chuan-Sheng Lin

Chia-Chen Lu

Chen-Yaw Chiu

Yun-Fei Ko

Hsin-Chih Lai

David Marcelo Ojcius

Jian-Ching Liau

Tsung-Ru Wu

I-Te Chang

Wei-Chang Wang

John D Young

Mei-Feng Lin

Chia-Jen Yang

Chien-Sheng Lee

Ding-E Young

Wei-Ting Jian

The present invention describes a method to reduce blood aspartate transaminase level, liver weight, hepatic lipid accumulation and hepatocyte hypertrophy by administering the probiotic bacteriumto a subject showing signs of fatty liver disease. This probiotic bacterium can therefore be used to treat fatty liver disease.

[object Object]

The present invention provides a method to reduce insulin resistance and improve glucose tolerance by administering the probiotic bacterium. This probiotic bacterium can therefore be used to treat insulin resistance, metabolic syndrome, and type 2 diabetes.

The present invention describes a method to reduce body weight, fat accumulation and adipocyte size by administering the probiotic bacterium. This probiotic bacterium can therefore be used to treat obesity in animals and humans.

The present invention provides a method to prepare polysaccharides from. The prepared polysaccharides can reduce hyperglycemia and insulin resistance, and can therefore be used to prevent and treat type 2 diabetes and related conditions.

The present invention provides a method to prepare polysaccharides from. The prepared polysaccharides reduce body weight and fat accumulation in laboratory animals, and can therefore be used to prevent and treat obesity.

Method to prepare hirsutella sinensis polysaccharides possessing anti-obesity properties and uses thereof

The present invention provides a method to prepare polysaccharides from. The prepared polysaccharides can reduce liver size, weight and the number and size of liver lipid vacuoles, as well as serum triglycerides and serum aspartate aminotransferase levels in humans and animals. The prepared polysaccharides can therefore be used to prevent and treat fatty liver disease.

The present invention provides a method to prepare polysaccharides from. The prepared polysaccharides can reduce liver weight and liver lipid content in humans and animals. The prepared polysaccharides can therefore be used to prevent and treat fatty liver disease.

The present invention provides a method to prepare polysaccharides from. The prepared polysaccharides can reduce hyperglycemia and improve insulin sensitivity in humans and animals, and can therefore be used to prevent and treat type 2 diabetes.

Growing community of inventors

Taipei, Taiwan

Jan Martel